What was recalled
This page synthesizes the preservation-function framework around rosemary extract in commercial pet food and the adjacent seizure-concern framework. Rosmarinus officinalis (now classified as Salvia rosmarinus) is a Mediterranean evergreen herb in the Lamiaceae family. Two distinct commercial products derive from the plant. Rosemary essential oil is produced via steam distillation of fresh or dried rosemary leaves and contains volatile aromatic compounds — primarily 1,8-cineole (15-40%), alpha-pinene (5-25%), camphor (5-20%), borneol (1-10%), and small amounts of thujone, verbenone, and other terpenes. The essential oil is used in aromatherapy, topical applications, and as a culinary flavor enhancer at low concentration. Rosemary extract is produced via solvent extraction (ethanol, water, supercritical CO2) of dried rosemary leaves and contains predominantly non-volatile phenolic compounds — carnosic acid, carnosol, and rosmarinic acid. The extract is the form used in pet food preservation and is compositionally distinct from the essential oil despite the shared botanical source.
The antioxidant mechanism of rosemary extract in pet food involves carnosic acid and carnosol acting as lipid-phase chain-breaking antioxidants. Carnosic acid donates a hydrogen atom from its phenolic hydroxyl group to lipid peroxyl radicals, terminating the lipid oxidation chain reaction. The resulting carnosic acid radical is stabilized by the orthoquinone resonance and forms a relatively stable end-product that does not propagate further radical reactions. Carnosol functions similarly with somewhat lower antioxidant potency. The combined activity provides oxidation protection comparable to BHA / BHT synthetic antioxidants at typical pet food inclusion levels, though stability of the rosemary extract itself through processing and storage is lower than synthetic alternatives. Rosmarinic acid is a water-soluble phenolic that provides aqueous-phase antioxidant activity complementary to the lipid-phase activity of carnosic acid and carnosol.
Why it was recalled
The structural framework has three notable aspects. Aspect one — essential oil versus extract distinction: the seizure concern in epileptic dogs derives from rosemary essential oil exposure, not from dietary rosemary extract in pet food. Camphor and thujone are the pro-convulsant compounds in rosemary essential oil; both are GABAergic antagonists at sufficient concentration, lowering seizure threshold in epileptic dogs and dogs with idiopathic epilepsy. Rosemary essential oil contains 5-20% camphor by weight; a 5 mL dose of essential oil contains approximately 200-1,000 mg camphor. Rosemary extract used in pet food preservation contains much lower camphor concentration (typically <0.1% camphor by weight after solvent extraction concentrates the phenolic compounds and reduces volatile content). A pet food formulation with 1,000 mg/kg rosemary extract contains approximately 1 mg camphor per kg of finished pet food — orders of magnitude below the essential oil exposure scenarios driving the seizure concern.
Aspect two — pet-owner community concern versus evidence base: pet-owner concern about rosemary extract and epileptic dogs has propagated through online communities, with anecdotal reports of seizure events attributed to dietary rosemary extract exposure. Veterinary neurology consensus: dietary rosemary extract at typical pet food inclusion levels is unlikely to trigger seizures in epileptic dogs; controlled studies have not demonstrated a relationship. The anecdotal reports may reflect confounding factors (concurrent stress, medication non-compliance, undiagnosed structural epilepsy progression) rather than dietary rosemary extract specifically. Pet owners with epileptic dogs may reasonably prefer to avoid rosemary extract as a precautionary practice given the absence of definitive safety data, even if the actual risk is low. Brand-specific rosemary-extract-free formulations are available and accommodate this preference. The clinical decision-making framework should distinguish documented risk (essential oil, concentrated rosemary products) from theoretical risk (dietary extract at pet food inclusion levels).
Aspect three — preservation stability framework: rosemary extract provides oxidation protection comparable to BHA / BHT at pet food inclusion levels, but the rosemary extract itself degrades faster than synthetic alternatives. Carnosic acid oxidizes to carnosol during processing and storage; carnosol further oxidizes to less-active compounds over shelf life. Open-bag stability of rosemary-extract-preserved pet food is typically 4-6 weeks (similar to tocopherol-preserved formulations and shorter than BHA/BHT-preserved formulations at 8-12 weeks). Combination natural preservation (rosemary extract + mixed tocopherols + ascorbic acid + citric acid) extends stability beyond any single component alone; this combination approach is the dominant natural preservation strategy in current premium pet food. The tocopherol preservation stability page covers the broader natural-versus-synthetic preservation framework.
Health risks for your pet
The clinical health-risk profile of rosemary extract at typical pet food inclusion levels (200-2,000 mg/kg finished formulation) is minimal in healthy dogs and cats. Dogs with diagnosed epilepsy warrant individualized risk assessment: the dietary rosemary extract risk is theoretical and likely small, but precautionary avoidance is reasonable in dogs with poorly-controlled epilepsy or recent seizure escalation. Cats do not have a well-established rosemary-related seizure concern, and the precautionary framework is less broadly applied; some cat owners and veterinary holistic-medicine practitioners avoid rosemary extract in cat food as a general precaution given limited feline-specific safety data. Pregnant queens and bitches warrant caution with rosemary essential oil exposure (smooth muscle stimulation, theoretical abortifacient effect at high dose); dietary rosemary extract at pet food inclusion levels has not been associated with reproductive adverse events.
The structural concern is essential oil exposure outside the pet food context rather than dietary rosemary extract specifically. Pet owners using rosemary essential oil for aromatherapy diffusion, topical application to dogs (including spot-on flea repellents containing rosemary essential oil), or accidental ingestion exposure should be aware of the concentrated thujone/camphor profile and the potential seizure-threshold-lowering effect in epileptic dogs. Rosemary essential oil is sold in concentrated form (often 100% essential oil) and a small ingestion exposure can deliver substantial camphor dose. Cats are particularly sensitive to essential oils generally (limited glucuronidation capacity reduces clearance of phenolic and terpene compounds); rosemary essential oil exposure in cats warrants more caution than in dogs. The pet food context is much lower-risk than the essential oil context.
What to do if you bought affected product
Pet owners can manage rosemary extract concerns through several practical approaches: (1) distinguish essential oil from extract — pet food rosemary extract is compositionally different from rosemary essential oil; the seizure concern derives from essential oil exposure rather than dietary extract; (2) epileptic dogs with poorly-controlled seizures or recent escalation warrant precautionary avoidance of rosemary essential oil exposure (aromatherapy diffusion, topical application, accidental ingestion); dietary rosemary extract avoidance is reasonable as a precautionary practice though the actual risk is low; (3) rosemary-extract-free pet food options are available; inspect ingredient deck or contact brand customer service to verify; some brands position this explicitly for epilepsy-aware pet owners; (4) do not use rosemary essential oil topically on dogs or cats without veterinary direction; "natural flea repellent" essential oil products containing rosemary essential oil have produced seizure events in epileptic dogs and warrant caution generally; cats are particularly sensitive to essential oils; (5) discuss with veterinary neurologist if your dog has diagnosed epilepsy with poor seizure control; the rosemary discussion fits within a broader epilepsy management framework that prioritizes medication compliance, stress reduction, identification of seizure triggers, and emergency seizure response protocols; (6) combination natural preservation systems (rosemary extract + mixed tocopherols + ascorbic acid + citric acid) provide better preservation than any single component; bag-size selection and airtight storage matter more than preservation system composition for practical open-bag freshness. The kibble fat coating oxidation framework covers the broader preservation context.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 awards scoring credit for rosemary extract inclusion as part of natural combination preservation systems per our published methodology, since the preservation function is well-established and the natural-source framing aligns with consumer preferences in premium and natural-positioning categories. The rubric does not penalize rosemary extract inclusion based on theoretical seizure-trigger concerns, since the dietary-extract risk in epileptic dogs is not robustly documented and the essential-oil-versus-extract distinction is structural. Pet owners with epileptic dogs may reasonably prefer rosemary-extract-free formulations as a precautionary practice; brand-level options are available. The structural preservation framework is well-established; ongoing veterinary research may clarify any epilepsy-specific dietary considerations over time, though current consensus does not support broad rosemary extract avoidance in epileptic dogs.